Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ZUMZ stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ZUMZ investment potential.

What is ZUMZ stock price today?

Get real-time ZUMZ stock price, historical data, and price charts on Financhill. Track ZUMZ performance with our advanced analysis tools.

Is ZUMZ a good investment?

Evaluate ZUMZ investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ZUMZ stock?

To buy ZUMZ stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ZUMZ?

View detailed market capitalization data and company valuation metrics for ZUMZ on our comprehensive analysis page.

What is the P/E ratio of ZUMZ?

Use our fundamental analysis tools to view ZUMZ P/E ratio and compare valuation metrics with industry peers.

What are ZUMZ earnings?

View ZUMZ earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Zumiez, Inc. 10K Form

Buy

ZUMZ
Zumiez, Inc.

Last Price:

$27.20

Seasonality Move:

5.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-06-10	10Q	ZUMZ/Zumiez, Inc. Quarterly
2023-12-04	10Q	ZUMZ/Zumiez, Inc. Quarterly
2023-09-07	10Q	ZUMZ/Zumiez, Inc. Quarterly
2023-06-05	10Q	ZUMZ/Zumiez, Inc. Quarterly
2022-12-05	10Q	ZUMZ/Zumiez, Inc. Quarterly
2022-09-08	10Q	ZUMZ/Zumiez, Inc. Quarterly

Receive ZUMZ News And Ratings

See the #1 stock for the next 7 days that we like better than ZUMZ

ZUMZ Financial Statistics

Sales & Book Value

Annual Sales:	$889.2M
Cash Flow:	$9.5M
Price / Cash Flow:	39.32
Annual Sales:	$16.98
Price / Book:	1.6

Profitability

EPS (TTM):	-0.00510
Net Income (TTM):	$581K
Gross Margin:	$283.1M
Return on Equity:	0.19%
Return on Assets:	0.09%

Zumiez, Inc. Earnings Forecast

Key Zumiez, Inc. Financial Ratios

The Gross Profit Margin over the past 25 years for ZUMZ is 31.84%.
The Selling, General & Administrative Expenses for ZUMZ have been equal to 33.86% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Net Earning history of ZUMZ is -0.19% of Total Revenues.
Per Share Earnings over the last 25 years have been positive in 15 years.

Zumiez, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Specialty Retail
Sector:	Consumer Discretionary
Current Symbol:	ZUMZ
CUSIP:	989817
Website:	zumiez.com

Debt

Debt-to-Equity Ratio:	0.71
Current Ratio:	1.76
Quick Ratio:	0.75

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	40.09

ZUMZ Technical Analysis vs Fundamental Analysis

Buy

Zumiez, Inc. (ZUMZ) is a Buy

Is Zumiez, Inc. a Buy or a Sell?

Zumiez, Inc. stock is rated a Buy

The current Zumiez, Inc. [ZUMZ] share price is $27.26. The Score for ZUMZ is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.